NCT01082965View on ClinicalTrials.gov

Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

NATerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Alzheimer's Disease
Interventions
DRUG

Donepezil

5 mg tablets once daily for 7 days and then 10mg on 8th day

DRUG

Placebo

matching placebo

Trial Locations (8)

19104

Pfizer Investigational Site, Philadelphia

19446

Pfizer Investigational Site, Philadelphia

21224

Pfizer Investigational Site, Baltimore

21287

Pfizer Investigational Site, Baltimore

63108

Pfizer Investigational Site, St Louis

63110

Pfizer Investigational Site, St Louis

94122

Pfizer Investigational Site, San Francisco

94143

Pfizer Investigational Site, San Francisco

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY